fda glp-1 compounding enforcement november 2025 issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA's GLP-1 decision kicks off

The resulting suspensions were washed thoroughly with unbuffered 7H9 medium to remove residual nutrients

They're not listed on Finnrick which, at this point in 2026, is the benchmark for vendor trustworthiness

Final Thoughts GLP-1 medications like Semaglutide and Tirzepatide arent just about losing weighttheyre about rewiring biology and psychology to restore balance

However, participants in the trials did not have to pay for the medications

In a cross-sectional study of older adults (60% with overweight or obesity) greater adherence to Mediterranean-like diets (MedDiet and prudent diet) were associated with lower circulating 3-hydroxy fatty acids levels, a proxy of LPS burden (121)